EUVIMEDEUVIMED entdecken
Crossref

Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma

Atsushi Miki, Yasunaru Sakuma, Takumi Teratani, Hideki Sasanuma, Wataru Nishimura, Hironori Yamaguchi

Anticancer Research · 2025

DOI: 10.21873/anticanres.17860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Atsushi Miki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan; amiki@jichi.ac.j…. Hauptthemen laut MEDLINE: Bilirubin, Bile Duct Neoplasms, Klatskin Tumor, Serum Albumin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: The Albumin-Bilirubin (ALBI) score was initially developed to estimate prognosis in patients with hepatocellular carcinoma. Recently, its prognostic relevance has been extended to intrahepatic cholangiocarcinoma; however, its impact on perihilar cholangiocarcinoma remains unclear. PATIENTS AND METHODS: A total of 71 patients who underwent hepatectomy for perihilar cholangiocarcinoma between 2007 and 2024 at Jichi Medical University were retrospectively analyzed. Preoperative blood samples were obtained within two weeks before surgery, after effective jaundice control. Survival outcomes were evaluated using the Kaplan-Meier method and compared with the log-rank test. Cox proportional hazards modeling was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for overall survival. RESULTS: Patients with ALBI Grade 1 had a significantly longer median survival time compared to those with ALBI Grade 2 or 3 (not reached vs. 45 months vs. 13 months, respectively; p=0.001). The prognostic nutritional index (PNI) was significantly lower in ALBI Grade 2/3 than in Grade 1 (41.6±5.7 vs. 49.5±5.9, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BilirubinBile Duct NeoplasmsKlatskin TumorSerum AlbuminHumansMaleFemaleMiddle AgedPrognosisAgedRetrospective StudiesHepatectomyKaplan-Meier EstimateAdultBiomarkers, Tumor

Stichwörter der Autor:innen

ALBIAlbuminbilirubinprognosissurvival

Substanzen

BilirubinSerum AlbuminBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan; amiki@jichi.ac.jp.
  • Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichi Medical University, Shimotsuke, Japan.
  • Division of Cell Biology and Anatomy, Jichi Medical University, Shimotsuke, Japan.

Zitieren

APA

Miki, A., Sakuma, Y., Teratani, T., Sasanuma, H., Nishimura, W., & Yamaguchi, H. (2025). Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17860

Vancouver

Miki A, Sakuma Y, Teratani T, Sasanuma H, Nishimura W, Yamaguchi H. Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma. Anticancer Research. 2025. doi:10.21873/anticanres.17860

BibTeX
@article{Miki2025,
  author = {Miki, Atsushi and Sakuma, Yasunaru and Teratani, Takumi and Sasanuma, Hideki and Nishimura, Wataru and Yamaguchi, Hironori},
  title = {Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17860}
}
Kostenlos starten →